Regionally limited or rare infections: prevention after hematopoietic cell transplantation
Bone Marrow Transplant
.
2009 Oct;44(8):489-94.
doi: 10.1038/bmt.2009.260.
Authors
J Gea-Banacloche
1
,
H Masur
,
C Arns da Cunha
,
T Chiller
,
L V Kirchhoff
,
P Shaw
,
M Tomblyn
,
C Cordonnier
;
Center for International Blood and Marrow Transplant Research
;
National Marrow Donor Program
;
European Blood and Marrow Transplant Group
;
American Society of Blood and Marrow Transplantation
;
Canadian Blood and Marrow Transplant Group
;
Infectious Disease Society of America
;
Society for Healthcare Epidemiology of America
;
Association of Medical Microbiology and Infectious Diseases Canada
;
Centers for Disease Control and Prevention
Affiliation
1
Experimental Transplantation and Immunology, National Cancer Institute, NIH, Bethesda, MD 20892-1203, USA. banacloj@mail.nih.gov
PMID:
19861983
DOI:
10.1038/bmt.2009.260
No abstract available
Publication types
Practice Guideline
MeSH terms
Antibiotic Prophylaxis
Hematopoietic Stem Cell Transplantation*
Humans
Opportunistic Infections / prevention & control*